drugset / Trial / NCT00062283

Alanosine in Treating Patients With Cancer

NCT00062283 ↗

Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy such as alanosine use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well alanosine works in treating patients with soft tissue sarcoma, sarcoma of the bone, mesothelioma, non-small cell lung cancer, or pancreatic cancer.

Timeline

Start
2003-03
Primary completion
2005-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject alanosine Small molecule — Intravenous